Lazard Serves as Financial Advisor to Xerox in Debt Exchange Transaction
Lazard is acting as the financial advisor to Xerox Holdings Corporation in a transaction to exchange a portion of its 2028 debt maturities for new notes and common stock.
Stocks · News reference
Lazard is serving as the financial advisor to Gilead Sciences in its agreement to acquire an investigational oral IL-23R inhibitor program from PepStar Therapeutics Ltd.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Lazard is acting as the financial advisor to Xerox Holdings Corporation in a transaction to exchange a portion of its 2028 debt maturities for new notes and common stock.
Lazard is acting as a financial advisor to Wyyerd Fiber in connection with its transaction involving Oak Hill Capital.
Lazard served as a financial adviser to Motive Partners in its acquisition of the UK-based pension investment platform Mobius from Phoenix Equity Partners.
Lazard is serving as a co-manager for Meta Platforms' recently announced $37.5 billion share offerings.